Pfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure raises investor concerns about Pfizer's 2026 forecast and succession plans. The company is preparing to enter the obesity drug market. Pfizer's shares were down in early trading. A search for a permanent successor is underway.

Pfizer Announces Chief Financial Officer Transition

Pfizer’s chief financial officer Dave Denton will soon wave goodbye to the world of pharma, pivoting back to the consumer goods industry four years after he joined the ranks of…